Dr. Thomas Lievens
ActiveDr. Thomas Lievens has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €379k and a net result of €124k. Equity is growing by ~49.7% per year across the filed fiscal years. Its solvency ranks better than 84% of 19908 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2024
88
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency100=
Growth78=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30k at 30 days acceptable
Liquidity ample (current ratio 16.1 against 14.85 in 2023; short-term debt: 5.2% and cash: 4.5% of total assets), and 9.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
90.9%
Return on assets
29.7%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 09-07-2025, 22 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
not confirmed
2024
22 d early
2023
21 d early
2022
20 d early
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€379k▲ 47.5%
2023 · €257k
2022: €123k
2023: €257k
2022 → 2024
Total assets
€416k▲ 40.7%
2023 · €296k
2022: €165k
2023: €296k
2022 → 2024
Net result
€124k▼ 8.5%
2023 · €135k
2022: €121k
2023: €135k
2022 → 2024
Working capital
€326k▲ 69.1%
2023 · €193k
2022: €151k
2023: €193k
2022 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202220232024Trend
Equity€123k-€257k▲ 108%€379k▲ 47.5%
Operating result€157k-€175k▲ 11.6%€160k▼ 8.7%
Net result€121k-€135k▲ 11.7%€124k▼ 8.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 9% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €416k
Fixed assets
€69k▼ 22.9%
Current assets
€348k▲ 68.2%
Equity and liabilities €416k
Equity
€379k▲ 47.5%
Debt
€38k▼ 3.7%
The debt ratio falls from 13.3% to 9.1%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€182k▼
2023 · €195k
Cash flow
€146k▼
2023 · €154k
Solvency
90.9%▲
2023 · 86.7%
Current ratio
16.10▲
2023 · 14.85
Quick ratio
16.10▲
2023 · 14.85
Debt / equity
0.10▼
2023 · 0.15
ROE
32.6%▼
2023 · 52.6%
ROA
29.7%▼
2023 · 45.6%
Interest coverage
495.06▼
2023 · 569.84
Debt
€38k▼
2023 · €39k
Debt ≤ 1 year
€22k▲
2023 · €14k
Debt > 1 year
€15k▼
2023 · €24k
Income taxes
€36k▼
2023 · €40k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€296k€416k▲
Fixed assets21/28€89k€69k▼
Tangible fixed assets22/27€89k€69k▼
Plant, machinery and equipment23€2k€3k▲
Furniture and vehicles24€88k€66k▼
Current assets29/58€207k€348k▲
Amounts receivable within one year40/41€6k€5k▼
Trade receivables40€3k€2k▼
Other amounts receivable41€3k€3k=
Current investments50/53-€320k
Cash at bank and in hand54/58€197k€19k▼
Deferred charges and accrued income490/1€4k€4k=
Equity and liabilities
Total equity and liabilities10/49€296k€416k▲
Equity10/15€257k€379k▲
Contributions10/11€3k€3k=
Reserves13€254k€376k▲
Distributable reserves133€254k€376k▲
Profit (loss) carried forward14-€0
Amounts payable17/49€39k€38k▼
Amounts payable after more than one year17€24k€15k▼
Financial debts170/4€24k€15k▼
Amounts payable within one year42/48€14k€22k▲
Current portion of amounts payable after more than one year42€9k€9k=
Trade debts44€1k€940▼
Suppliers440/4€1k€940▼
Taxes, remuneration and social security45€87€6k▲
Taxes450/3€87€6k▲
Other amounts payable47/48€4k€6k▲
Accrued charges and deferred income492/3€1k€977▼
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€19k€22k▲
Other operating charges640/8€1k€1k▲
Gross operating margin9900€196k€184k▼
Operating profit (loss)9901€175k€160k▼
Financial income75/76B€0€0▼
Recurring financial income75€0€0▼
Financial charges65/66B€342€368▲
Recurring financial charges65€342€368▲
Profit (loss) for the period before taxes9903€175k€160k▼
Income taxes67/77€40k€36k▼
Profit (loss) for the period9904€135k€124k▼
Profit (loss) for the period to be appropriated9905€135k€124k▼
Appropriation of the result
Profit (loss) to be appropriated9906€135k€124k▼
Transfer from equity791/2€1k€2k▲
Transfer to equity691/2€135k€124k▼
To other reserves6921€135k€124k▼
Profit to be distributed694/7€1k€2k▲
Return on contributions (dividend)694€1k€2k▲
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
09-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
10-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Highest result since 2022net €135k ▲11.7%
Operating result €175k, net result €135k, both a record.
31-12
Financial
Equity above €200kEq €257k ▲108%
2 profitable years in a row build equity to €257k.
11-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Geel · 1 establishment unit since 2021
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Kievermont 512440 GeelGround area
4,452 m²
Building footprint
509 m²
Volume, LiDAR
3,285 m³
2 parcels, Flanders · tallest building 10.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Dr. Thomas Lievens
since 20212.323.574.721
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13008I2144/00E002 | Flanders | 3,178 m² | 1 · 196 m² | 10.6 m · 2 fl. |
| 13036F0480/00X000 | Flanders | 1,274 m² | 1 · 313 m² | 9.1 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Medisch Huis 't Rondpunt
BE 0538.867.662
Laakdal · Eq €379k
HUISARTSENPRAKTIJK COLLA EN VERMARIEN
BE 0894.356.232
Dilsen-Stokkem · Eq €378k
VAN WASSENHOVE - HUISARTS
BE 0845.888.302
Sint-Lievens-Houtem · Eq €379k
JOSE CUELENAERE
BE 0434.277.908
Waremme · Eq €378k
DR. CÉDRIC DE JAEGER - ALGEMENE EN SPORTGENEESKUNDE
BE 0735.601.478
Deinze · Eq €379k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,093 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded29-10-2021
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Data from official sources, last processed on 23-09-2026. Scores and ratios are computed by Checked and are not a credit decision.